Search results
Left in limbo: When pharma halts rare disease research
Pharmaceutical Technology· 3 days agoEarlier this month, Pirovolakis mentioned that the FDA greenlit Elpida’s plans to initiate a Phase...
Earlier this month, Pirovolakis mentioned that the FDA greenlit Elpida’s plans to initiate a Phase...